We are live on
!
Find out more
IAP
Indie Asset Partners Portfolio holdings
AUM
$104M
1-Year Est. Return
31.76%
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+31.76%
3 Year Est. Return
+118.95%
5 Year Est. Return
+164.44%
10 Year Est. Return
–
AUM
$133M
AUM Growth
-$4.68M
(-3.4%)
Cap. Flow
+$665K
Cap. Flow
% of AUM
0.5%
Top 10 Holdings %
Top 10 Hldgs %
59.63%
Holding
133
New
7
Increased
44
Reduced
48
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$4.72M |
| 2 |
First Internet Bancorp
INBK
|
+$544K |
| 3 |
Zimmer Biomet
ZBH
|
+$468K |
| 4 |
Global X Copper Miners ETF NEW
COPX
|
+$452K |
| 5 |
Meta Platforms (Facebook)
META
|
+$358K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$1.93M |
| 2 |
Marvell Technology
MRVL
|
+$516K |
| 3 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$420K |
| 4 |
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
|
+$397K |
| 5 |
Commault Systems
CVLT
|
+$348K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.12% |
| 2 | Technology | 10.06% |
| 3 | Consumer Discretionary | 4.09% |
| 4 | Industrials | 3.44% |
| 5 | Financials | 3.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Bank of America
BAC
$440B
| $317K | 0.24% |
7,686
+97
| +1% | +$4.38K |
|
77
Global X Uranium ETF
URA
$6.2B
| $317K | 0.24% |
+12,100
| New | +$281K |
|
78
Vanguard S&P 500 ETF
VOO
$1.01T
| $317K | 0.24% |
764
| – | – |
|
79
Lam Research
LRCX
$388B
| $312K | 0.23% |
5,800
-100
| -2% | -$5.82K |
|
80
Thermo Fisher Scientific
TMO
$216B
| $311K | 0.23% |
526
| – | – |
|
81
Biogen
BIIB
$30.3B
| $305K | 0.23% |
1,449
-205
| -12% | -$44.6K |
|
82
Walt Disney
DIS
$181B
| $304K | 0.23% |
2,217
+6
| +0.3% | +$867 |
|
83
Shopify
SHOP
$194B
| $298K | 0.22% |
4,410
-200
| -4% | -$16.4K |
|
84
Caterpillar
CAT
$388B
| $297K | 0.22% |
1,335
| – | – |
|
85
Alphabet (Google) Class C
GOOG
$4.35T
| $296K | 0.22% |
2,120
-160
| -7% | -$21.8K |
|
86
PayPal
PYPL
$50.7B
| $295K | 0.22% |
2,549
+338
| +15% | +$45K |
|
87
United Parcel Service
UPS
$88.8B
| $294K | 0.22% |
1,372
+56
| +4% | +$11.9K |
|
|
NVO
88
Novo Nordisk
NVO
$208B
| $293K | 0.22% |
5,272
-186
| -3% | -$9.55K |
|
89
PENN Entertainment
PENN
$2.72B
| $292K | 0.22% |
6,885
-190
| -3% | -$8.68K |
|
90
FedEx
FDX
$75.1B
| $287K | 0.22% |
1,241
-450
| -27% | -$106K |
|
91
Lowe's Companies
LOW
$124B
| $287K | 0.22% |
1,419
+15
| +1% | +$3.45K |
|
92
Vanguard Morningstar Total Stock Market ETF
VTI
$685B
| $287K | 0.22% |
1,260
+126
| +11% | +$28.3K |
|
93
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.38B
| $286K | 0.21% |
5,850
-100
| -2% | -$4.95K |
|
94
Zebra Technologies
ZBRA
$17.9B
| $285K | 0.21% |
690
-145
| -17% | -$66.6K |
|
95
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.51B
| $280K | 0.21% |
9,645
-6,000
| -38% | -$179K |
|
96
Amgen
AMGN
$219B
| $272K | 0.2% |
1,123
| – | – |
|
97
Cisco
CSCO
$477B
| $271K | 0.2% |
4,862
| – | – |
|
98
Ares Capital
ARCC
$14.3B
| $270K | 0.2% |
12,895
| – | – |
|
99
GSK
GSK
$106B
| $266K | 0.2% |
4,880
+360
| +8% | +$19.6K |
|
100
Lumen
LUMN
$6.53B
| $265K | 0.2% |
23,500
| – | – |
|
Similar funds
HMS
BWS
MAM
EEL
JMA
P
WCBA
EW
Indie Asset Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Indie Asset Partners held 133 positions worth $133M, down 3.4% from $138M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Indie Asset Partners's Q1 2022 filing shows 7 new, 44 increased, 48 reduced and 9 closed positions. Its largest new stake was First Internet Bancorp: 11,250 shares worth $484K. The largest sale was Royalty Pharma, an estimated $1.93M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 42% a quarter earlier, followed by Technology and Consumer Discretionary.
- Indie Asset Partners's largest Q1 2022 buy was First Internet Bancorp: 11,250 shares worth $484K.
- Indie Asset Partners added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q1 2022, an estimated $4.72M increase.
- Indie Asset Partners's biggest Q1 2022 reduction was Royalty Pharma, cutting an estimated $1.93M.
- Indie Asset Partners fully exited Marvell Technology in Q1 2022, selling an estimated $516K.
- Indie Asset Partners's ten largest holdings make up 60% of its $133M portfolio in Q1 2022.
- Indie Asset Partners opened 7 new positions and closed 9 in Q1 2022.
- Indie Asset Partners's portfolio value fell 3.4% quarter-over-quarter to $133M.
Based on Indie Asset Partners's 13F filing for Q1 2022, filed 10 May 2022.